FIORELLA ROCCA: Open Payments
NPI 1588319685 · NORTH LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 89 payments from 22 companies in 2025. Trend: 2023 $2,908 · 2024 $2,017 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $464 |
| Novo Nordisk Inc | 12 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $161 |
| Lilly USA, LLC | 11 | $156 |
| PFIZER INC. | 7 | $150 |
| ABBVIE INC. | 4 | $101 |
| Dexcom, Inc. | 5 | $99 |
| Astellas Pharma US Inc | 3 | $61 |
| Amgen Inc. | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
Products named: AIRSUPRA, FARXIGA, Kerendia, MOUNJARO, NURTEC ODT, Dexcom G6 Transmitter, Veozah, XIFAXAN.
Industry payments across NV — which companies pay providers there.
